This is “in line with our expectations” and shows that the group is slowly transitioning to business as usual, RHB analyst Shekhar Jaiswal writes in a Feb 22 note.
Analysts have taken a strong liking for Raffles Medical Group following its results for FY2021 ended Dec 31.
The healthcare services provider’s full-year earnings rose by 27.7% to $84.2 million, from $65.9 million in the year before, thanks to stronger revenue growth.
